CEMRACanadian Electrical Manufacturers Representatives Association (est. 1981; Toronto, Ontario, Canada)
CEMRAContrast-Enhanced Pulmonary Magnetic Resonance Angiography
References in periodicals archive ?
Although DSA is considered as a gold standard in the evaluation of peripheral vessels, especially in peripheral vascular disease, the role of DSA has now been challenged by recent advances in technology like colour Doppler, CTA and CEMRA.
In the majority of cases, CEMRA is performed as breath-hold, non-ECG-triggered "first pass" imaging (FP-MRA) after injection of an extracellular fluid (ECF) gadolinium based contrast agent (GBCA).
Ninety-two percent of CEMRA patients required no additional procedures and experienced no adverse events at 30 days, compared with 82 percent of DSA patients.